search icon
  • What's New in Practice Management & Payment

    AMA Releases an Interactive Web-based Tool for MIPS

    CMS Releases 2018 Medicare Physician Fee Schedule Proposed Rule

    CMS: Fact Sheet for the QPP Year 2 Proposed Rule

    AMA Releases New MIPS Resources

    CMS Releases Lookup Tool to Help Clinicians Determine their MIPS Participation Status

  • News from IDSA and Journals


    Benefits of Direct-Acting Antivirals for Hepatitis C


    Leaders of IDSA and AASLD have published an editorial in the Annals of Internal Medicine outlining their concerns with a recent review by the Cochrane Group of the guidance provided in the organizations’ HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. The organizations and chairs of the guidance panel have also expressed their concerns directly to the Cochrane Group.



  • CDC and FDA Alerts

    10/5/2017 6:54:35 PM

    FDA approves first test for screening Zika virus in blood donations

    FDA approves first test for screening Zika virus in blood donations The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors. 

    10/4/2017 1:14:59 PM

    Potentially blinding complication following intraocular injections of compounded vancomycin formulation - Drug Information Update

    Hemorrhagic occlusive retinal vasculitis (HORV) is a rare, potentially blinding postoperative complication that has been observed in dozens of patients who have received intraocular injections of vancomycin (anti-infective) formulations toward the end of otherwise uncomplicated cataract surgeries.

    9/29/2017 5:00:42 PM

    Candida auris Clinical Update- September 2017

    Candida auris is an emerging, multidrug-resistant yeast that causes invasive infections and is transmitted in healthcare settings.

    10/4/2017 11:49:50 AM

    FDA approves new drug for bacterial vaginosis

    Today FDA approved a new medication for bacterial vaginosis. This treatment is the first one-dose oral regimen for the most common vaginal infection in women 15-44 years of age.

    9/13/2017 4:53:22 PM

    Rifampin/Penicillin-Resistant Strain of RB51 Brucella Contracted from Consumption of Raw Milk

    The Texas Department of State Health Services, with assistance from CDC, is investigating Brucella RB51 exposures and illnesses that may be connected to the purchase and consumption of raw (unpasteurized) milk from K-Bar Dairy in Paradise, Texas.

    9/12/2017 3:15:14 PM

    Tetanus in Areas Affected by a Hurricane: Risk, Prevention, and Management Guidelines for Clinicians

    Exposure to flood waters does not increase the risk of tetanus. Therefore, tetanus immunization campaigns for evacuees from flooding disasters are not needed. 

    9/12/2017 11:49:08 AM

    Hurricane Irma—Clinical Guidance for Carbon Monoxide (CO) Poisoning

    Hurricane Irma, one of the largest hurricanes in history, caused an over 7.7 million households to lose power.

    9/12/2017 11:37:18 AM

    Hurricane Harvey—Clinical Guidance for Carbon Monoxide (CO) Poisoning

    Carbon monoxide (CO) is an odorless, colorless, poisonous gas that can cause sudden illness and death if present in sufficient concentration in the ambient air. 

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site